
- Other
- Current
Dyne Therapeutics is developing a pipeline of RNA-based therapeutics targeting an array of neuromuscular disorders. Its lead program has demonstrated in vivo muscle knock-down.
dyne-tx.comDyne Therapeutics is developing a pipeline of RNA-based therapeutics targeting an array of neuromuscular disorders. Its lead program has demonstrated in vivo muscle knock-down.
dyne-tx.com